Stay updated with breaking news from Bioaffinity Technologies. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
BioAffinity Technologies, Inc. (NASDAQ:BIAF – Get Rating)’s stock price was down 1% during mid-day trading on Tuesday . The company traded as low as $2.02 and last traded at $2.03. Approximately 8,182 shares traded hands during trading, a decline of 99% from the average daily volume of 983,699 shares. The stock had previously closed at […]
BioAffinity Technologies, Inc. , a biotechnology company focused on the need for noninvasive, accurate tests for the detection of early-stage cancer, today announced that Michael Dougherty has joined... | May 1, 2023
BioAffinity Technologies today announced it appointed Michael Dougherty as chief financial officer, effective immediately.
BioAffinity Technologies (NASDAQ:BIAF – Get Rating) and iSpecimen (NASDAQ:ISPC – Get Rating) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their profitability, valuation, analyst recommendations, earnings, institutional ownership, risk and dividends. Profitability This table compares bioAffinity Technologies and iSpecimen’s net margins, […]
31.03.2023 - bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW), a biotechnology company addressing the need for noninvasive detection of early-stage lung cancer and other diseases of the lung, today reported financial results for the three and 12 months ended ...